Physician profile
Todd Drexel
NPI 1437259108
$5,010.92
in general payments reported to CMS, 2019-2025
49 companies · $721 in 2025
The $721 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $157 · 2021: $662 · 2022: $964 · 2023: $857 · 2024: $827 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,405.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $880.05 | 2020-2024 | Ova1 |
| Biogen, INC. | $436.41 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $418.08 | 2020-2025 | Orilissa, Lo Loestrin Fe |
| Allergan, INC. | $299.25 | 2019 | |
| Astellas Pharma US INC | $226.03 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $222.74 | 2022-2025 | Nexplanon |
| Axonics, INC. | $182.22 | 2021-2023 | Bulkamid, Axonics |
| Novo Nordisk INC | $165.40 | 2019-2023 | Wegovy, Saxenda |
| Sumitomo Pharma America, INC. | $165.38 | 2023-2025 | Myfembree |
| Boston Scientific Corporation | $157.41 | 2022-2025 | Bulkamid, Advantage System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Intuitive Surgical, INC. | $151.18 | 2020-2021 | |
| Shield Therapeutics INC | $144.07 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $134.56 | 2021-2023 | |
| Amgen INC. | $112.24 | 2019 | |
| Channel Medsystems, INC. | $106.42 | 2023 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Drexel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.